Implantable cardiac defibrillator infections: the emerging importance of Mycobacterium fortuitum.
Menfil A Orellana-BarriosDavid A Sotello AvilesOlusegun OyenugaKenneth NugentPublished in: BMJ case reports (2017)
Infection is a clinically relevant complication associated with intracardiac devices. Atypical mycobacteria, particularly Mycobacterium fortuitum, have been increasingly implicated in cardiovascular implantable electronic device (CIED) infections. We present a case of M. fortuitum CIED infection in a patient with ischaemic cardiomyopathy occurring approximately 3 weeks after insertion. The recognition and adequate treatment, including device removal, tissue sampling and the determination of antimicrobial sensitivities, are essential in the proper management of these patients.
Keyphrases
- end stage renal disease
- mycobacterium tuberculosis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- heart failure
- prognostic factors
- left ventricular
- molecularly imprinted
- patient reported outcomes
- cardiac resynchronization therapy
- mass spectrometry
- atrial fibrillation
- gestational age
- smoking cessation
- simultaneous determination